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Abstract
Objective To investigate the effects of lifestyle and
vascular-related risk factors for Alzheimer’s disease (AD)
on in vivo MRI-based brain atrophy in asymptomatic young
to middle-aged adults.
Design Cross-sectional, observational.
Setting Broader New York City area. Two research centres
affiliated with the Alzheimer’s disease Core Center at New
York University School of Medicine.
Participants We studied 116 cognitively normal
healthy research participants aged 30–60 years,
who completed a three-dimensional T1-weighted
volumetric MRI and had lifestyle (diet, physical activity
and intellectual enrichment), vascular risk (overweight,
hypertension, insulin resistance, elevated cholesterol
and homocysteine) and cognition (memory, executive
function, language) data. Estimates of cortical
thickness for entorhinal (EC), posterior cingulate,
orbitofrontal, inferior and middle temporal cortex were
obtained by use of automated segmentation tools. We
applied confirmatory factor analysis and structural
equation modelling to evaluate the associations
between lifestyle, vascular risk, brain and cognition.
Results Adherence to a Mediterranean-style diet (MeDi)
and insulin sensitivity were both positively associated
with MRI-based cortical thickness (diet: βs≥0.26, insulin
sensitivity βs≥0.58, P≤0.008). After accounting for vascular
risk, EC in turn explained variance in memory (P≤0.001).
None of the other lifestyle and vascular risk variables
were associated with brain thickness. In addition, the path
associations between intellectual enrichment and better
cognition were significant (βs≥0.25 P≤0.001), as were
those between overweight and lower cognition (βs≥-0.22,
P≤0.01).
Conclusions In cognitively normal middle-aged adults,
MeDi and insulin sensitivity explained cortical thickness
in key brain regions for AD, and EC thickness predicted
memory performance in turn. Intellectual activity and
overweight were associated with cognitive performance
through different pathways. Our findings support
further investigation of lifestyle and vascular risk factor
modification against brain ageing and AD. More studies

Strengths and limitations of this study
►► One of the key strengths of this study is the avail-

ability of a well-characterised population of asymptomatic middle-aged healthy adults with multiple
lifestyle and vascular risk measures, as well as
neuroimaging.
►► Our statistical approach using confirmatory factor
analysis and structural equation modelling allowed
us to simultaneously discern the independent and
inter-related effects of several lifestyle variables and
vascular risk factors on brain atrophy and cognition.
►► A limitation of the study was its cross-sectional nature. Longitudinal studies with larger samples are
necessary to test for temporal and causal inter-relationship between modifiable risk factors and future
Alzheimer’s disease (AD).
►► We caution that participants were carefully screened
research participants, which limits our ability to generalise results to the entire population. More studies
are needed to replicate these research findings in
community-based settings.
►► MRI measures are largely seen as biomarkers of
neurodegeneration associated with AD. However,
biomarkers specific to AD pathology (amyloid and
tau pathology) are warranted to determine whether
the associations between lifestyle and vascular risk
are indeed related to ongoing AD.

with larger samples are needed to replicate these research
findings in more diverse, community-based settings.

Introduction
Alzheimer’s disease (AD) is the most common
form of dementia, affecting nearly 34 million
people worldwide.1 Unless effective strategies
for prevention are found, the prevalence of
AD is expected to triple by 2050.
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Table 1 Participants’ demographic and clinical
characteristics
n
Age, years

116
50 (6), range 30–60

Sex, % female

62

Education, years

16 (2), range 12–22

Family history of LOAD, %
positive

38

APOE ε4 carriers, % positive

40

Ethnicity, % white

68

Subjective complaints, %
positive

44

Laboratory findings
 BMI (kg/cm2)

25 (4), range 18–37

 Hypertension, % positive

14

 QUICKI score (unitless)

0.32 (0.03)

 Plasma cholesterol/HDL ratio
(unitless)

3.3 (0.8)

 Plasma homocysteine (µmol/L) 7.9 (6.2)

examined one or few variables at a time.7 Further,
although there is consensus that preventative interventions have the highest chances of success when implemented in midlife,2 the majority of studies focused on the
elderly, including those already experiencing cognitive
impairment.8–14
Neuropathologically, AD is characterised by the presence of amyloid-beta (Aβ) plaques, neurofibrillary tangles
and neuronal loss in selectively vulnerable brain regions.6
Neuronal loss in AD originates in the medial temporal
lobes during the normal stages of cognition and spreads
to cortical regions with disease progression.15 MRI has
long been used to visualise neurodegeneration in vivo.
Several MRI studies have shown that brain cortical thinning (ie, atrophy) in AD-vulnerable regions begins many
years prior to dementia onset, making this biomarker an
ideal candidate to monitor the effectiveness of preventative interventions.16
This study examines the simultaneous effects of
multiple modifiable lifestyle and vascular risk factors on
MRI-based cortical atrophy in a cohort of middle-aged
healthy adults at risk for AD.

Lifestyle measures
 Mediterranean diet (unitless)

4.3 (1.9), range 1–8

 Physical activity (metabolic
equivalent/hour)
 Intellectual activity (unitless)

9.8 (6.3), range 1–37
3.7 (0.7), range 1.8–4.9*

Values are mean (SD) unless otherwise specified.
*Data were not available for 20 out of 116 patients.
APOE, apolipoprotein E; BMI, body mass index; HDL, high-density
lipoprotein; LOAD, late-onset Alzheimer's disease; QUICKI,
Quantitative Insulin Sensitivity Check Index.

Given the current lack of disease-modifying treatment,2
and increasing awareness that AD pathology develops
over many years prior to clinical symptoms,3 the potential
for prevention is crucial to reduce AD risk and/or delay
the onset of cognitive decline.
There is substantial epidemiological evidence linking
modifiable risk factors, such as midlife hypertension,
obesity, diabetes, poor diet, physical and intellectual inactivity, with increased risk of late-onset AD. Recent population-attributable models estimated that one in every three
cases of AD may be accounted for by these lifestyle and
vascular-related risk factors.1 4 As a result, trends in AD
risk reduction research have focused on lifestyle interventions as well as vascular risk reduction.2 3 5
While the importance of lifestyle and vascular risk
management in health is well understood, their specific
effects on AD pathophysiology, and thus their effectiveness for AD prevention are less clear.6
Conflicting results in the literature may be due to the
use of different patient populations, different lifestyle
measures, different statistical constructs and an overall
lack of AD biomarkers. Moreover, though a combined
reduction in risk factors is projected to have a greater
impact than any one factor alone,4 most studies have
2

Methods
Participants
Participants were enrolled in observational brain imaging
studies of clinically and cognitively normal middle-aged
adults conducted at two research centres affiliated with
the Alzheimer’s disease Coordinating Center of New
York University (NYU) School of Medicine between
2010 and 2016. Details about the studies have previously
been published.17–21 All participants provided informed
consent to participate in this study.
Briefly, participants were derived from multiple
community sources, including individuals interested in
research participation, family members and caregivers
of impaired patients. Subjects were 30–60 years old, with
≥12-year education, Clinical Dementia Rating=0, Global
Deterioration Scale<2, Hamilton depression scale <16
and normal cognitive test performance for age and education.22 Because our goal was to examine the influence of
lifestyle and vascular risk factors in healthy middle-aged
participants without overt cardiovascular and/or cerebrovascular disease, we excluded individuals with Modified
Hachinski Ischaemia scale score >4. Those with medical
conditions or history of conditions that may affect brain
structure or function (eg, stroke, poorly controlled
diabetes, head trauma, any neurodegenerative diseases,
depression, hydrocephalus, intracranial mass and infarcts
on MRI) and those taking steroids or psychoactive medications were excluded. Only participants with clinical,
laboratory, neuropsychological, volumetric MRI examinations and lifestyle questionnaires within 6 months of each
other were included.
A family history of AD that included at least one first-degree relative whose AD onset was after age 60 was elicited using standardised questionnaires.17 Apolipoprotein
Mosconi L, et al. BMJ Open 2018;8:e019362. doi:10.1136/bmjopen-2017-019362
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Figure 1 Assessing the impact of lifestyle and vascular risk factors on brain ageing and cognition. Results of the following
SEMs. (A) Relationships between lifestyle, vascular risk and brain, excluding cognition from the model. (B) Relationships
between lifestyle, brain and cognition, excluding vascular risk from the model. (C) Relationships between vascular risk, brain
and cognition, excluding lifestyle from the model. Red lines indicate the significant effects observed in our data. Purple lines
indicate significant alternate paths. Blue lines indicate significant correlational effects. Grey lines indicate associations which
were tested but found to be non-significant. Numbers beside the lines are standardised beta coefficients and corresponding P
values: *P<0.01; **P<0.001. Not shown here, all brain ROI variables were correlated with one another (see online supplementary
etable 1). Direct associations between lifestyle and vascular risk factors are found in online supplementary etable 2. Variables
in squares are measured variables (eg, one variable represents this construct). Variables in circles are latent variables (multiple
variables were averaged using a CFA to represent that construct). Straight lines indicate causal relationships, curved lines
indicate correlational relationships. Age was entered as a covariate. Brain biomarkers were examined with and without adjusting
for total intracranial volume. CFA, confirmatory factor analysis; ROI, region of interest; SEMs, structural equation models.

E (APOE) genotypes were determined using standard
quantitative PCR procedures.17
Cognitive measures
The neuropsychological battery of tests was previously
described.22 Briefly, three cognitive domains were assessed
from the following tests: memory (immediate and delayed
recall of a paragraph and immediate and delayed recall
of paired associates), executive function (Wechsler Adult
Intelligence Scale (WAIS) digit symbol substitution) and
language (WAIS vocabulary).
We modelled memory as a latent factor composed
of standardised versions of immediate and delayed
recall scores using confirmatory factor analysis (CFA)
(alpha=0.84). The three cognitive domains were examined as outcome variables (see Statistical analysis).
Vascular risk measures
Vascular risk factors included in the model were: (1)
overweight, measured using the body mass index (BMI,
kg/m2); (2) presence of hypertension, conservatively
Mosconi L, et al. BMJ Open 2018;8:e019362. doi:10.1136/bmjopen-2017-019362

determined based on either current antihypertensive
treatment or blood pressure assessments; (3) elevated
plasma cholesterol and/or elevated plasma homocysteine,
as obtained after overnight fasting using standard laboratory procedures and (4) insulin sensitivity, measured with
the Quantitative Insulin Sensitivity Check Index,23 where
lower scores reflect greater insulin resistance and higher
scores reflect insulin sensitivity.
Lifestyle measures
Diet
Dietary data regarding average food consumption over
the prior year were obtained using the Block or Harvard
food frequency questionnaire, as previously described.19
Briefly, food items were categorised into food groups
based on similarities in food and nutrient composition, and intake of each food group was calculated by
summing the intakes of food group items. Mediterranean diet (MeDi) scores were generated as the sum of
caloric intake-adjusted daily gram intake dichotomised
3
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Table 2 Results of structural equation modelling for model
1: lifestyle, vascular risk and brain
βs

SE

P value

Associations between lifestyle and brain MRI biomarkers
0.260 0.099
0.009
 Diet → Brain
 Diet → Brain

0.204

0.086

 Physical activity → Brain

−0.130

0.108

 Physical activity → Brain

−0.058

0.047

 Intellectual enrichment →
Brain

−0.192

0.098

 Intellectual enrichment →
Brain

−0.190

0.102

0.018

Associations between vascular risk and brain MRI
biomarkers
 Overweight → Brain

−0.067

0.101

 Overweight → Brain

−0.116

0.173

 Insulin sensitivity → Brain

0.559

0.081

<0.001

 Insulin sensitivity → Brain

0.029

0.006

<0.001

 Plasma cholesterol/HDL →
Brain

−0.038

0.101

 Plasma cholesterol/HDL →
Brain

−0.010

0.037

 Plasma homocysteine →
Brain

0.177

0.315

 Plasma homocysteine →
Brain

0.175

0.372

 Hypertension → Brain
 Hypertension → Brain

0.076

0.106

0.032

0.042

The table consists of standardised betas (βs), their SEs and P
values of the estimates from the full model with age entered as a
covariate. The βs can be interpreted as partial correlations. Only
significant P values (two tailed) are reported. Paths in italics are
adjusted for sex and APOE status as covariates.
APOE, apolipoprotein E; HDL, high-density lipoprotein.

relative to the sex-specific median for each beneficial
(fruits, vegetables, legumes, cereals and fish; monounsaturated to saturated fat ratio; mild to moderate alcohol
consumption) versus detrimental (meat and dairy products) component.19 24 Greater score indicate greater
MeDi adherence.
Physical activity
The Baecke and Minnesota leisure time physical activity
questionnaires were used to estimate the current level
of physical activity.25 26 For each activity, information
was collected on the frequency and duration of engagement over the past year. Frequency and duration
data were multiplied with an activity-specific intensity
code indicating calorie expenditure. We standardised
and summed the activity-dependent scores from each
test to obtain the overall annual intensity of physical
activity per person, which was converted to metabolic
equivalents.
4

Intellectual enrichment
Intellectual activity and years of education were used as
measures of intellectual enrichment as described below.
Intellectual activity throughout life was assessed using a
validated 25-item interview in which participants were
asked to report how often they engaged in common
cognitively demanding activities that depend minimally on socioeconomic status, such as reading books
or newspapers, writing letters or e-mails, going to the
library and playing games at different age epochs.9 27
Previous studies described this instrument in detail and
reported high internal consistency and positive associations of intellectual activity with educational and cognitive performance.27
MRI acquisition and processing
All subjects received three-dimensional volumetric
T1-weighted MRI on a 3T scanner according to published
protocols.17–21 MRIs were acquired and preprocessed as
described.19 28 Volumetric segmentation, cortical surface
reconstruction and parcellation were performed using
the FreeSurfer V.5.3 software package.29 30 Cortical thickness measures were obtained for a subset of a priori-defined regions of interest (ROIs) known to show atrophic
changes early in AD and in association with lifestyle7:
entorhinal cortex (EC), posterior cingulate cortex (PCC),
orbitofrontal cortex, inferior and middle temporal gyrus.
FreeSurfer was also used to derive total intracranial
volumes (TIV) to adjust for individual variability.
A latent factor of brain structure was generated by
combining the ROI thickness measures using CFA to represent that construct. Instead of predicting each of these ROIs
individually, the latent factor predicts their shared variance
(ie, intercorrelation). EC was set as the marker variable. All
ROIs were strongly correlated with each other (alpha >0.78,
see online supplementary etable 1).
Statistical analysis
We constructed structural equation models (SEMs)
(MPlus V.731) to evaluate interdependent relationships
among the four sets of variables: lifestyle (diet, physical activity and intellectual enrichment), vascular-related risk (overweight, hypertension, insulin resistance,
elevated plasma cholesterol and homocysteine levels),
MRI biomarkers (latent variable of brain structure) and
cognitive measures (latent variable of memory, executive
function and language).
The three cognitive domains were modelled as a function of lifestyle variables, vascular variables and MRI
biomarkers (see online supplementary efigure 1). Lifestyle and vascular variables were specified as exogenous
variables. Brain structure formed an intermediate layer
of endogenous variables, and the cognitive domains were
the final downstream endogenous variables. As such,
exogenous variables (lifestyle and vascular risk measures)
predicted brain variables, and brain variables in turn
predicted cognition. We regressed brain structure on
the lifestyle and vascular variables. We then regressed
Mosconi L, et al. BMJ Open 2018;8:e019362. doi:10.1136/bmjopen-2017-019362
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cognitive domains on all other variables in the model.
Additionally, ran a separate model in which we replace
the latent variable of brain structure with the two limbic
regions (ie, EC and PCC) based on evidence of their
earlier predictive capacity.
Since variables in the two exogenous domains, lifestyle and vascular risk, were only marginally related to
each other (see Results), the model was further broken
down into the following three submodels: (1) we first
modelled the relationships between lifestyle, vascular risk
and brain, excluding cognition from the model; (2) we
modelled the relationships between lifestyle, brain and
cognition, excluding vascular risk and (3) we modelled
the relationships between vascular risk, brain and cognition, excluding lifestyle from the model.
All models were adjusted for the intercorrelations
between lifestyle variables, vascular-risk variables,
brain structure and cognitive measures as appropriate. Age, gender and APOE status were examined
as covariates. Brain measures were evaluated with and
without adjustment for TIV.
For each analysis, we first fit the full models, estimating all paths and then assessed the reduced models
suggested by the primary analysis (eg, with non-significant paths removed). We used χ2 statistic, comparative
fit index (CFI) and root mean square error of approximation (RMSEA) goodness of fit tests to indicate model
fits for the full models. Each of these measures incorporates unique criteria to assess fit so a summary of all three
measures provides a more comprehensive estimate. After
the path coefficients were derived, the paths were thresholded to achieve a second, more parsimonious model, by
eliminating paths with P values >0.05. Path elimination
was monitored via the χ2, CFI and RMSEA. Good model
fit can be reflected by a χ2 to df ratio <2.0,32 a CFI>0.8533
and an RMSEA<0.06.34 The CFI and RMSEA are among
the measures least affected by sample size and perform
very well at all sample sizes.32 As such, CFI and RMSEA
were our primary reporting criteria for the reduced
models.
Some of the reduced models were saturated (eg, these
models accounted for all possible relationships that
could exist among variables in our dataset), making
overall model fit statistics not applicable. In this case, we
focused on specific paths and path significance rather
than omnibus measures model fits. The standardised
beta coefficients (βs) can be interpreted as partial correlations. Given that all of the paths are standardised, one
can judge meaningfulness by their raw and comparative
path weights. All analyses used maximum likelihood estimation in the MPlus package.31
Results
Participants
A total of 116 participants were included in the analysis
(table 1). Participants were on average 50 years old (range
25–60), 62% women, with education ≥12 years. Of these,
Mosconi L, et al. BMJ Open 2018;8:e019362. doi:10.1136/bmjopen-2017-019362

38% had a family history of AD, and 40% had at least one
copy of the APOE4 allele (APOE4 carriers).
Structural equation modelling
In the full model, age was associated with risk of hypertension (βs=0.18, P=0.049) and, although it tended to be
negatively related to brain structure (βs=−0.10 to −0.19,
ns), it was not significantly associated with the lifestyle or
cognitive variables.
Men, as expected, showed higher vascular risk than
women, as reflected in a higher frequency of hypertension,
elevated cholesterol and homocysteine levels (P<0.04).
Women showed better executive function performance
than men (P<0.001). Sex was not significantly or marginally
related to lifestyle variables or brain structure.
APOE status was not associated with lifestyle or cognitive variables but was associated with plasma cholesterol
(P=0.033) and marginally associated with brain structure
(P=0.07). These effects were driven by APOE4 carriers
exhibiting higher cholesterol levels and reduced cortical
thickness than non-carriers.
Given these relationships, all subsequent analyses were
performed with and without adjusting for age, sex and
APOE, as appropriate.
Among lifestyle variables, with and without controlling
for the above confounds, participants with higher intellectual enrichment showed higher MeDi adherence
(βs≥0.27, P≤0.028). Otherwise, lifestyle variables were not
significantly related to one another.
Among vascular variables, BMI was negatively associated with insulin sensitivity (βs=−0.27, P<0.01) and positively associated with cholesterol levels and hypertension
(βs=0.32 and βs=0.29, P<0.001). Cholesterol levels and
hypertension were associated with each other (βs=0.24,
P<0.05).
Vascular and lifestyle variables were not associated with
each other, except for higher intellectual enrichment
correlating with lower risk of hypertension (βs=−0.22,
P<0.05), and insulin sensitivity was marginally, though not
significantly, associated with diet (βs=0.12, P=0.18). The
model was therefore broken down in the following three
submodels:
Lifestyle, vascular risk and MRI-based biomarkers
Figure 1 represents the path diagrams from model 1,
which exhibited adequate fit, χ2(41)≥95.37, RMSEA<0.05,
CFI≥0.85, P<0.001. Controlling for age, diet and insulin
sensitivity were the only factors positively associated
with brain structure (βs≥0.26 and βs≥0.58, respectively,
P≤0.008, table 2). The reduced model fit the data well
(RMSEA <0.01, CFI≥0.90) reflecting the fact that diet and
insulin sensitivity both significantly and independently
predicted brain structure (diet: βs=0.20, P=0.017 and
insulin sensitivity: βs=0.57, P<0.001), consistent with the
pattern of significant and non-significant paths obtained
in full model 1. Including sex and APOE status as covariates did not significantly influence these relationships
(table 2).
5
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Figure 2 Assessing the impact of lifestyle and vascular risk factors on limbic brain structures and cognition. Results of the
following SEMs. (A) Relationships between lifestyle, vascular risk and limbic brain, excluding cognition from the model. (B)
Relationships between lifestyle, limbic brain and cognition, excluding vascular risk from the model. (C) Relationships between
vascular risk, limbic brain and cognition, excluding lifestyle from the model. See legend to figure 1. Age was entered as a
covariate. Brain measures were examined with and without adjusting for total intracranial volume. *P<0.01; **P<0.001. EC,
entorhinal cortex; PCC, posterior cingulate cortex; SEMs, structural equation models.

Restricting analysis to limbic structures fit the data well
(RMSEA <0.05, CFI=1.0), confirming that insulin sensitivity was positively associated with both EC and PCC
(βs=0.42 and βs=0.38, P<0.001), and diet was associated
with PCC (βs=0.23, P=0.004) and marginally with EC
(βs=0.13, P=0.12) (figure 2).

PCC (βs=0.27, P=0.006) and EC (βs=0.17, P=0.08), which
in turn positively, though marginally, predicted memory
(βs=0.19, P=0.078) (figure 2).
Including sex and APOE status as covariates did not
influence the other relationships of interest in any of the
models (table 3).

Lifestyle, MRI-based biomarkers and cognition
Model 2 exhibited adequate fit, χ2(64)≥108.51, RMSEA
<0.05, CFI≥0.90, P<0.001. The reduced models were
completely saturated (eg, all possible relationships that
could exist among variables in the dataset were accounted
for). As such, we focused on specific paths and path significance rather than omnibus measures of model fit.
As in model 1, with and without adjusting for age and
TIV, diet was the only lifestyle factor positively associated
with brain structure (βs≥0.27, P≤0.02, table 3 and figure 1).
Diet and physical activity were not associated with cognitive
function, whereas intellectual enrichment was positively
associated with cognition (P<0.05, table 3). Specifically,
intellectual activity was positively associated with memory
and executive function (βs=0.28 and βs=0.39, respectively,
P<0.02), and marginally with language (βs=0.25, P=0.08).
Education positively predicted memory, executive function and language (βs=0.21–0.33, P≤0.038).
Brain structure was not significantly associated with
cognition. However, when analyses were restricted to
limbic structures, diet showed positive associations with

Vascular risk, MRI-based biomarkers and cognition
Model three exhibited adequate fit, χ 2(78)≥151.54,
RMSEA <0.05, CFI≥0.89, P<0.001. The reduced
models were completely saturated and overall model
fit statistics were not applicable. Below, we focus on
path significance rather than omnibus measures of
model fit.
As in model 1, insulin sensitivity was the only vascular
factor associated with brain structure (βs=0.58, P<0.01,
table 4 and figure 1). Brain structure was not significantly
associated with cognition. However, when analysis was
restricted to limbic structures, insulin sensitivity showed
positive associations with EC (βs=0.30, P<0.001) and EC
in turn positively predicted memory (βs=0.39, P<0.001)
(figure 2). Additionally, BMI was negatively associated
with memory and executive function (βs=−0.22 and
βs=−0.27, P≤0.021, figure 2).
Including sex and APOE status as covariates did not
significantly influence the other relationships of interest
(table 4).

6
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Table 3 Results of structural equation modelling for model
2: lifestyle, brain and cognition
βs

SE

Table 4 Results of structural equation modelling for model
3: vascular risk, brain and cognition
βs

P value

Associations between lifestyle and brain MRI biomarkers

SE

P value

 Diet → Brain

0.253

0.098

0.010

Associations between vascular risk and brain MRI
biomarkers

 Diet → Brain

0.253

0.099

0.010

 Overweight → Brain

−0.067

0.101

−0.129

0.107

 Overweight → Brain

−0.116

0.173

0.126

 Insulin sensitivity → Brain

0.559

0.081

<0.001

 Insulin sensitivity → Brain

0.029

0.006

<0.001

 Physical activity → Brain
 Physical activity → Brain

−0.132

 Intellectual enrichment → Brain
  Intellectual activity → Brain
  Education → Brain

−0.113
−0.164

0.125

 Plasma cholesterol/HDL → Brain

−0.038

0.101

0.099

 Plasma cholesterol/HDL → Brain

−0.010

0.037

 Intellectual enrichment → Brain

 Plasma homocysteine → Brain

0.177

0.315

  Intellectual activity → Brain

−0.112

0.124

 Plasma homocysteine → Brain

0.175

0.372

  Education → Brain

−0.168

0.099

 Hypertension → Brain

0.076

0.106

 Hypertension → Brain

0.032

0.042

Associations between brain and cognitive measures
 Brain → Memory

0.050

0.118

Associations between brain and cognitive measures

 Brain → Memory

0.064

0.094

 Brain → Memory

0.032

0.125

0.042

0.123

 Brain → Executive function

−0.034

0.101

 Brain → Memory

 Brain → Executive function

−0.041

0.100

 Brain → Executive function

−0.032

0.101

−0.037

0.101

 Brain → Language

−0.314

0.094

 Brain → Executive function

 Brain → Language

−0.318

0.094

 Brain → Language

−0.325

0.095

 Brain → Language

−0.327

0.095

Associations between lifestyle and cognitive measures
 Diet → Memory

0.033

0.113

Associations between vascular risk and cognitive measures

 Diet → Memory

0.023

0.092

 Overweight → Memory

−0.195

0.119

−0.191

0.119

 Diet → Executive function

0.023

0.099

 Overweight → Memory

 Diet → Executive function

0.042

0.099

 Overweight → Executive function

−0.230

0.091

0.012

 Diet → Language

0.068

0.107

 Overweight → Executive function

−0.229

0.091

0.012

 Diet → Language

0.063

0.107

 Overweight → Language

−0.006

0.095

 Physical activity → Memory

0.070

0.113

 Overweight → Language

−0.008

0.095

 Physical activity → Memory

0.052

0.094

 Insulin sensitivity → Memory

0.082

0.116

 Physical activity → Executive function

0.002

0.099

 Insulin sensitivity → Memory

0.041

0.124

 Physical activity → Executive function

0.007

0.098

−0.072

0.097

 Physical activity → Language

0.002

0.102

 Insulin sensitivity → Executive
function

 Physical activity → Language

−0.009

0.102

−0.064

0.096

0.278

0.114

 Insulin sensitivity → Executive
function
 Insulin sensitivity → Language

−0.480

0.075

<0.001

 Insulin sensitivity → Language

−0.490

0.074

<0.001

 Plasma homocysteine → Memory

−0.298

0.164

 Plasma homocysteine → Memory

−0.183

0.196

 Plasma homocysteine → Executive
function

−0.190

0.140

 Plasma homocysteine → Executive
function

−0.188

0.122

 Plasma homocysteine → Language

−0.218

0.338

 Plasma homocysteine → Language

−0.358

0.294

 Intellectual enrichment → Memory

0.014

 Intellectual activity → Memory
 Education → Memory

0.213

0.102

0.038

Intellectual enrichment → Executive
function
 Intellectual activity → Executive function

0.385

0.101

<0.001

 Education → Executive function

0.329

0.084

<0.001

 Intellectual activity → Language

0.251

0.135

 Education → Language

0.325

0.084

<0.001

Intellectual enrichment → Memory

0.184

0.094

0.050

 Cholesterol/HDL → Memory

−0.051

0.115

 Intellectual enrichment → Executive
function

0.327

0.084

0.001

 Cholesterol/HDL → Memory

−0.042

0.112

 Intellectual enrichment → Language

0.326

0.084

0.001

 Cholesterol/HDL → Executive
function

−0.138

0.097

 Cholesterol/HDL → Executive
function

−0.030

0.101

 Cholesterol/HDL → Language

−0.057

0.096

Intellectual enrichment → Language

The table consists of standardised betas (βs), their SEs, and P values of
the estimates from the full model with age entered as a covariate. The
βs can be interpreted as partial correlations. Only significant P values
(two tailed) are reported. Paths in italics are adjusted for sex and APOE
status as covariates.
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Table 4 Continued
βs

SE

 Cholesterol/HDL → Language

−0.052

0.095

 Hypertension → Memory

−0.084

0.129

 Hypertension → Memory

−0.084

0.130

 Hypertension → Executive function

−0.092

0.099

 
Hypertension → Executive function

−0.073

0.098

 Hypertension → Language

−0.176

0.095

 
Hypertension → Language

−0.179

0.094

P value

The table consists of standardised betas (βs), their SEs, and P values
of the estimates from the full model with age entered as a covariate.
The βs can be interpreted as partial correlations. Only significant P
values (two tailed) are reported. Paths in italics are adjusted for sex
and APOE status as covariates.
HDL, high-density lipoprotein.

Discussion
The major conclusions of this study were the following:
(1) among lifestyle and vascular risk factors, diet and
insulin sensitivity explained variability in brain cortical
thickness in cognitively healthy, middle-aged adults; (2)
MRI measures of limbic structures in turn explained variability in memory performance; (3) intellectual enrichment and increased BMI explained variability in cognitive
performance through different pathways.
Our results indicate that diet and insulin sensitivity may
be among the earliest modifiable risk factors to influence
the expression of AD biomarkers, suggesting these modifiable risk factors may alter risk of AD pathophysiology
during middle age. These associations were independent
of age, sex and APOE genotype.
Findings of associations between lower MeDi adherence and increased brain atrophy are consistent with the
literature in the elderly.19 24 35 36 Likewise, we and others
have described strong associations between insulin resistance and limbic cortex atrophy in both adolescents and
non-demented elderly.20 28 37 Our data extend prior observations to a population of middle-aged healthy adults
and offers a comprehensive view of how the interplay of
lifestyle and vascular factors influences possible AD risk.
Indeed, besides being linked with lower risk of dementia,
the MeDi was shown to support healthier insulin regulation and cardiovascular health.38 Given the known
increased AD risk associated with prediabetes and type 2
diabetes,39 our findings fit with increased cardiovascular
risk being a driver of increased brain ageing and AD.
The statistical approach we employed allowed us to
simultaneously examine several lifestyle and vascular
risk factors and discern their independent as well as
intercorrelated effects on brain atrophy and cognition.
Other studies that used SEM reported minimal or null
associations between physical and intellectual activities
and AD biomarkers in non-demented elderly, although
biomarkers independently predicted cognitive function.12 40 These studies, however, did not take into account
diet or vascular risk. Our study in a younger cohort
8

(mean age 50 vs 78–82 years12 40) indicates that physical and intellectual activity do not impact brain ageing
as much as diet does during the normal stages of cognition. When vascular risk factors were accounted for in
the model, insulin sensitivity influences cortical thickness
and its effects on limbic regions had significant effects
on memory performance. These effects were present
accounting for the impact of exercise, intellectual activity
and additional vascular risk factors.
In our cohort, insulin resistance was strongly associated
with increased BMI (ie, overweight). Although BMI was
not directly associated with MRI measures, it negatively
impacted memory and executive function through other
pathways. It has long been known that midlife obesity
affects cognitive performance,41 possibly by promoting
cardiovascular disease (CVD) and Aβ deposition.42
Additionally, intellectual enrichment was associated
with better cognitive performance, suggesting a protective effect on AD risk. It is possible that continued intellectual stimulation may lower the risk or delay the onset
of AD by enhancing cognitive reserve, as suggested by
studies in the elderly.9 11–14 40
Several issues require further consideration. First, our
results are cross-sectional and do not allow for determination of causality or temporal relationships between lifestyle, vascular risk, brain biomarkers and cognitive status.
Studies with larger samples and longitudinal follow-ups
are needed to examine lifestyle and vascular risk factors
as possible AD risk modifiers. From a statistical perspective, even though our model fits were adequate and the
observed relationships were supported by the data, the
associations were not so strong to yield an ideal model fit.
To better evaluate the impact of modifiable risk factors on
brain ageing, we performed additional linear regression
analyses to estimate R-squared values for the predictors
identified in the reduced SEM models. R-squared is the
‘per cent of variance explained’ by the model (eg, the
fraction by which the variance of the errors is less than
the variance of the dependent variable). As with SEM
analysis, diet and insulin sensitivity were both significant predictors of brain structure, yielding a combined
R-squared=0.28 (age adjusted), P<0.001. In other words,
the combination of diet and insulin sensitivity explained
28% of the variance in brain MRI measures. Additionally, intellectual enrichment and BMI explained 11%
and 8% of the variance in cognitive measures, respectively (P≤0.022). As such, these modifiable risk factors
were fairly good predictors after adjusting for all other
variables in the model. The associations were nonetheless modest, which is not unexpected in a relatively
young, healthy population. That said, caution should be
exerted in interpreting these data. For instance, some of
the null associations may depend on sample size limitations. However, null effects observed in our cohort are
consistent with negative findings from large-scale studies
in the elderly.12 40 Therefore, we offer that the strongest
arguments of the study are the significant findings which
manifest themselves despite these limitations. Overall,
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our data suggest that lifestyle and vascular risk have an
impact on brain ageing during midlife, thus supporting
further investigation of modifiable risk factors for healthy
brain ageing and AD risk reduction.
As with other studies in asymptomatic at-risk individuals,18 43 44 imaging biomarkers were only modestly
associated with cognitive measures, most likely because
our patients were all cognitively normal and younger
than 60. Previous studies have demonstrated that
associations between brain biomarkers and cognition
are evident in clinical populations, such as those with
clear brain pathology but not among normal populations.45 Nonetheless, associations between limbic MRI
measures and memory were significant, indicating that
modifiable risk factors may impact cognitive health
before old age.
We cannot exclude that our screening criteria may
have biased effect estimates.46 For instance, participation was limited to healthy, middle-aged individuals
without severe cardiac and CVD. Our goal was to identify possible vascular, metabolic and lifestyle correlates
of brain health, prior to severe disease and at a young
enough age for potential interventions to be impactful.
However, this makes our population restricted in the variability of cardiometabolic disease. As such, our results are
only relevant to middle-aged, cognitively normal, healthy
men and women without active CVD, stroke or diabetes.
Nonetheless, our results are in keeping with prospective,
community-based studies of non-diabetic populations
showing that insulin resistance and increased blood
sugar levels, even at levels considered normal in standard
glucose tests, increase AD risk.47
Another limitation of the study pertains to the characterisation of lifestyle habits. We used self-report questionnaires of diet and lifestyle, which are vulnerable to
error and may not have captured relevant dimensions of
lifestyle activities that influence cognitive functioning.
Additionally, given the cross-sectional nature of our study
and synchronous timing of lifestyle and MRI assessments,
we cannot exclude the possibility that dietary adherence
or physical activity levels were short-term choices in this
cohort, which are less likely to impact brain biomarkers
than long-term choices. However, 90% of participants
reported living the lifestyle assessed in the surveys for 5
years or more.
Although MRI measures of neurodegeneration are
sensitive to early AD changes, they are believed to
emerge after changes in neuronal activity and downstream to Aβ accumulation.16 As such, MRI measures
are not specific to AD and offer limited information
on whether the observed associations were due to AD
or to other causes of cortical thinning. Amyloid and
tau biomarkers specific to AD are warranted to investigate the potential of lifestyle and vascular risk intervention for AD prevention. However, Aβ deposition is
an age-dependent phenomenon, with 0% of cognitively
normal individuals aged 45–49 years and less than 6%
of those in the fifth decade of life testing positive for
Mosconi L, et al. BMJ Open 2018;8:e019362. doi:10.1136/bmjopen-2017-019362

Aβ.48 Considering that all our participants were cognitively normal and between 30 and 60 years of age, very
few (if any) would have had substantial amyloid burden,
making this cohort an ideal population for testing of
primary prevention strategies.
We caution that present results were found in small
numbers of carefully screened patients who were evaluated under controlled clinical conditions. Longitudinal
studies with larger samples are needed to replicate and
assess the generalisability of these preliminary findings in community-based populations with higher variability in socioeconomic and medical status, as well as to
incorporate other AD biomarkers. Should preventative
studies prove successful, work will be needed to estimate
the effects of increased longevity on dementia burden
in such an increasingly older, although healthier,
population.
In conclusion, our results suggest that a well-rounded
lifestyle that incorporates a healthy diet (such as the
MeDi), reduces vascular risk factors (especially insulin
resistance and overweight) and promotes intellectual
activity might be neuroprotective during ageing. More
studies are needed to evaluate midlife lifestyle and
vascular risk factor modification for AD prevention.
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